comparemela.com

Actinium Pharma (ATNM) Reports Iomab-B Phase 3 SIERRA Trial Results Demonstrating Survival Benefit in High-Risk Relapsed or Refractory Acute Myeloid Leukemia Patients

Actinium Pharma (ATNM) Reports Iomab-B Phase 3 SIERRA Trial Results Demonstrating Survival Benefit in High-Risk Relapsed or Refractory Acute Myeloid Leukemia Patients

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom ,Glasgow ,Glasgow City ,Scotland ,Avinash Desai ,Actimaba National Cancer Institute ,Exchange Commission ,European Bone Marrow Transplant Society ,Actinium Pharmaceuticals Inc ,Actinium Pharmaceuticals ,Antibody Radiation Conjugates ,Complete Remission ,Overcomes High Risk ,Scottish Event Campus ,Chief Medical Officer ,North African ,Annual Meeting ,National Cancer Institute ,

comparemela.com © 2020. All Rights Reserved.